This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Atai Therapeutics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Setu Kasera: Innovator in N,N-Dimethyltryptamine Research
Introduction
Setu Kasera is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmacology, particularly in the development of N,N-dimethyltryptamine (DMT) compounds. Her work is pivotal in exploring the therapeutic potential of these substances.
Latest Patents
Setu holds a patent for N,N-dimethyltryptamine salts and crystalline salt forms, specifically a N,N-dimethyltryptamine (DMT) succinate crystalline form. This patent represents a significant advancement in the formulation of DMT, which may have implications for various therapeutic applications. She has 1 patent to her name.
Career Highlights
Setu is currently employed at Atai Therapeutics Inc., a company focused on developing innovative treatments for mental health disorders. Her role involves extensive research and development, contributing to the company's mission of transforming the treatment landscape for mental health.
Collaborations
Setu collaborates with talented individuals in her field, including Majed Fawaz and Nicholas Morra. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the pharmaceutical industry.
Conclusion
Setu Kasera is a pioneering inventor whose work in DMT research is shaping the future of mental health treatment. Her contributions and collaborations are vital to the ongoing exploration of innovative therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile